Administration of ENBREL should be discontinued if a patient develops a serious infection. Caution should be exercised when considering the use of ENBREL in patients with a history of recurring or ...

SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...

THOUSAND OAKS, Calif. & COLLEGEVILLE, Pa. -- Amgen and Wyeth Pharmaceuticals, a division of Wyeth, today announced updates to the U.S. Food and Drug Administration (FDA)-approved U.S. Prescribing ...

The safety of etanercept in this patient population was established through multiple pediatric trials, including a clinical study in 69 children aged 2 to 17 years with moderately to severely active ...

Sandoz has filed an antitrust lawsuit in the US against Amgen, challenging alleged anti-competitive practices surrounding the biologic blockbuster Enbrel (etanercept). Filed at the US District Court ...

Oct. 14, 2004 — The U.S. Food and Drug Administration (FDA) has approved caspofungin acetate for the empiric treatment of presumed fungal infections in the setting of febrile neutropenia, etanercept ...

Samsung Bioepis confirmed to Focus via email Friday that the company’s biosimilar to Amgen’s Enbrel (etanercept), to be known as Eticovo (etanercept-ykro), has been approved by the US Food and Drug ...

THOUSAND OAKS, Calif., Nov. 22, 2011 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement: Amgen today announced the issuance of U.S. Patent No. 8,063,182 related to Enbrel ® ...

The patient waiting list already had soared to tens of thousands for the rheumatoid arthritis drug Enbrel when Amgen Inc. sent its biotech SWAT team of 100 experts to Rhode Island last spring on a ...

Image source: Amgen via Flickr. Amgen (NASDAQ: AMGN), the original biotech blue-chip company, reported its third-quarter earnings results after the closing bell on Thursday, handily surpassing Wall ...